. home.aspx

home.aspx
   

FDA Gives Nod To 1st Sinusitis Drug That Includes Nasal Polyps

July 03, 2019 / ANDREW BARNES

In what specialists have termed to a pivotal point, the FDA approved a chronic sinusitis drug, a disease which causes polyps in the sinuses. Names Dupixent, the injection is administered every 2 weeks. Those with chronic rhinosinusitis and nasal polyps will be treated with this drug. FDA stated that nasal polyps cause damage to smell abilities and require surgery for treatment. Dupixent is termed to provide treatment alternatives for those whose polyps can’t be controlled via intranasal steroids. This decreases the requirement for oral steroids and polyp surgery. Specialists have applauded this move.